These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 23615182

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
    Manchanda PK, Kumar A, Kaul A, Mittal RD.
    Clin Chim Acta; 2006 Aug; 370(1-2):152-7. PubMed ID: 16545788
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor gene polymorphisms in North Indian patients with end stage renal disease.
    Prakash S, Prasad N, Sharma RK, Faridi RM, Agrawal S.
    Cytokine; 2012 May; 58(2):261-6. PubMed ID: 22370607
    [Abstract] [Full Text] [Related]

  • 6. Role of non-HLA genetic variants in end-stage renal disease.
    Ranganath P, Tripathi G, Sharma RK, Sankhwar SN, Agrawal S.
    Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
    [Abstract] [Full Text] [Related]

  • 7. Cytokine (IL-10 -1082 and -819) and chemokine receptor (CCR2 and CCR5) gene polymorphism in North Indian patients with end-stage renal disease.
    Manchanda PK, Singh R, Mittal RD.
    DNA Cell Biol; 2009 Apr; 28(4):177-83. PubMed ID: 19196047
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C, Isman FK, Dasdemir S, Cakmakoglu B, Sanli O, Gokkusu C, Seckin S.
    Gene; 2012 Dec 10; 511(1):7-11. PubMed ID: 22982413
    [Abstract] [Full Text] [Related]

  • 11. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
    Misra MK, Prakash S, Kapoor R, Pandey SK, Sharma RK, Agrawal S.
    Tissue Antigens; 2013 Nov 10; 82(5):317-26. PubMed ID: 24131018
    [Abstract] [Full Text] [Related]

  • 12. Association between vitamin D receptor gene polymorphisms and susceptibility to chronic kidney disease and periodontitis.
    de Souza CM, Braosi AP, Luczyszyn SM, Avila AR, de Brito RB, Ignácio SA, Probst CM, Riella MC, Sotomaior VS, Mira MT, Pecoits-Filho R, Trevilatto PC.
    Blood Purif; 2007 Nov 10; 25(5-6):411-9. PubMed ID: 17914260
    [Abstract] [Full Text] [Related]

  • 13. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
    Buraczynska M, Ksiazek P, Drop A, Zaluska W, Spasiewicz D, Ksiazek A.
    Nephrol Dial Transplant; 2006 Apr 10; 21(4):979-83. PubMed ID: 16384824
    [Abstract] [Full Text] [Related]

  • 14. Role of thrombotic risk factors in end-stage renal disease.
    Tripathi G, Sankhwar SN, Sharma RK, Baburaj VP, Agrawal S.
    Clin Appl Thromb Hemost; 2010 Apr 10; 16(2):132-40. PubMed ID: 19520684
    [Abstract] [Full Text] [Related]

  • 15. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
    Summers AM, Coupes BM, Brennan MF, Ralph SA, Short CD, Brenchley PE.
    Nephrol Dial Transplant; 2005 Nov 10; 20(11):2427-32. PubMed ID: 16046504
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of tumour necrosis factor-α polymorphism in patients with end stage renal disease.
    Singh K, Prasad KN, Mishra P, Singh SK, Kharwar NK, Prasad N, Gupta A, Srivastava JK.
    Nephrology (Carlton); 2015 Jun 10; 20(6):387-91. PubMed ID: 25589331
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
    Ma RC, Tam CH, Wang Y, Luk AO, Hu C, Yang X, Lam V, Chan AW, Ho JS, Chow CC, Tong PC, Jia W, Ng MC, So WY, Chan JC.
    JAMA; 2010 Aug 25; 304(8):881-9. PubMed ID: 20736472
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.